Detalhe da pesquisa
1.
Adalimumab drug and antidrug antibody levels do not predict flare risk after stopping adalimumab in RA patients with low disease activity.
Rheumatology (Oxford)
; 58(3): 427-431, 2019 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30383251
2.
Onset of rheumatoid arthritis after COVID-19: coincidence or connected?
Ann Rheum Dis
; 80(8): 1096-1098, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33648960
3.
Is radiographic progression a downside of stopping TNF-inhibitor in RA patients with low disease activity, if this is followed by flare? A sub-study of the POET-US trial.
Rheumatology (Oxford)
; 59(5): 1170-1171, 2020 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31652321
4.
Predictors of biologic-free disease control in patients with rheumatoid arthritis after stopping tumor necrosis factor inhibitor treatment.
BMC Rheumatol
; 3: 3, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31225430
5.
Multi-biomarker disease activity score as a predictor of disease relapse in patients with rheumatoid arthritis stopping TNF inhibitor treatment.
PLoS One
; 13(5): e0192425, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29791439
6.
Impaired Porphyromonas gingivalis-Induced Tumor Necrosis Factor Production by Dendritic Cells Typifies Patients With Rheumatoid Arthritis.
Arthritis Rheumatol
; 68(4): 795-804, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26606260
7.
Flare Rate in Patients with Rheumatoid Arthritis in Low Disease Activity or Remission When Tapering or Stopping Synthetic or Biologic DMARD: A Systematic Review.
J Rheumatol
; 42(11): 2012-22, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26428204